Previous 10 | Next 10 |
Shares of the clinical-stage biotech Gritstone Oncology (NASDAQ: GRTS) rose by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is heating up today in response to an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to initia...
Tenax Therapeutics, Inc. (TENX) +70% after announcing acquisition of PH Precision Med.Aclaris Therapeutics (ACRS) +66% on positive data from mid-stage rheumatoid arthritis.Minerva Neurosciences (NERV) +42% on announcing sale of Seltorexant Royalty for up to $155M.China Natural ...
Gritstone Oncology (GRTS) jumps 34% premarket in reaction to advancing development of a second generation vaccine against SARS-CoV-2, with potential for both prolonged protection and potency against Spike mutants.The company and the National Institute of Allergy and Infectious Disea...
--Gritstone to Host Conference Call Today at 8:00 a.m. ET-- EMERYVILLE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, today an...
EMERYVILLE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, presiden...
Gainers: Synthetic Biologics (SYN) +141%.Helius Medical Technologies (HSDT) +91%.The Peck Company (PECK) +79%.Atomera (ATOM) +50%.Check-Cap (CHEK) +49%.Naked Brand Group (NAKD) +42%.The9 (NCTY) +37%.Gritstone Oncology (GRTS) +36%.Boston Private Financial (BPFH) +31%.Jaguar Heal...
Are These Penny Stocks on Your Watch List Right Now? With the new year in full swing, investors are recharged and ready to find opportunities. When first searching for the “best penny stocks ” or at least the “best” for right now, there are a few things t...
Aileron Therapeutics (ALRN) +73%.Broadway Financial Corporation (BYFC) +55% after regulatory approvals for merger with CFBanc Corporation.Atlantic American Corporation (AAME) +43%.Marker Therapeutics (MRKR) +30% after FDA lifted the partial clinical hold on it's Phase 2 trial.Cyclo ...
Gainers: [[AAME]] +53.3%. [[BPFH]] +27.8%. [[AIH]] +11.4%. [[ASLN]] +11.2%. [[GRTS]] +10.1%.Losers: [[VRAY]] -11.1%. [[GDS]] -8.4%. [[PBYI]] -5.5%. [[ACY]] -5.4%. [[GBIO]] -5.3%. For further details see: AAME, AIH, GDS and VRAY among after-hours movers
EcoR1 Capital disclosed a 9.99% stake in Gritstone Oncology (GRTS), which represents over 4.87M shares.The filing does not allow for activism.Shares +9.3% during after hours. For further details see: Gritstone Oncology +9.3% AH, EcoR1 discloses ~10% stake in company
News, Short Squeeze, Breakout and More Instantly...
Gritstone Oncology Inc. Company Name:
GRTS Stock Symbol:
NASDAQ Market:
Gritstone Oncology Inc. Website:
2024-06-14 13:15:03 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for GRTS on June 14, 2024 11:01AM ET. The previous analyst recommendation was Market Outperform. GRTS was trading at $0.7575 at issue of the analyst recommendation. The overall analyst ...
2024-05-24 11:30:04 ET B. Riley analyst issues BUY recommendation for GRTS on May 24, 2024 09:31AM ET. The previous analyst recommendation was Buy. GRTS was trading at $0.8039 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
-- Favorable progression-free survival (PFS) trend observed in preliminary data from the randomized Phase 2 study evaluating GRANITE (personalized neoantigen vaccine) in front-line metastatic, microsatellite-stable colorectal cancer (MSS-CRC); mature PFS data expected in the third quarter of 2024...